AMCO International made and sold AED replacement batteries without required FDA approval, FDA says.
What happened
FDA inspected AMCO International's Brooklyn, NY facility from March 11, 2024, through March 20, 2024. The investigator found the firm manufactures replacement batteries used in AEDs, including AM9146-2, AM5070, and AM1000. FDA determined the firm had not submitted a required premarket approval (PMA) application by February 3, 2022, and continued to manufacture and distribute the batteries after that date.
What FDA found
AMCO made and distributed AED replacement batteries that require premarket approval without an approved application.
section 501(f)(1)(A) of the Act, 21 U.S.C. § 351(f)(1)(A)AMCO did not submit a premarket approval application for AM9146-2, AM5070, and AM1000 by the February 3, 2022, compliance date.
section 515(b) of the Act, 21 U.S.C. § 360e(b); 21 CFR 870.5310AMCO continued to manufacture and distribute those batteries after the compliance date.
section 501(f)(1)(A) of the Act, 21 U.S.C. § 351(f)(1)(A)AMCO also made and distributed 5L318, 6L785, 5L500, and AM9141 batteries for discontinued AEDs after the compliance date.
section 515(b) of the Act, 21 U.S.C. § 360e(b)
What FDA wants
FDA asks AMCO to stop activities that adulterate necessary AED accessories and to respond in writing within 15 business days with the steps taken, corrective actions, and a plan to prevent recurrence.
Who should pay attention
- AED manufacturers whose devices use these batteries
- distributors and resellers of AED accessories
- regulatory teams tracking PMA status for device accessories
This is a summary. Read the original letter on fda.gov.